CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Robust home brew fragment sizing assay for detection of MET exon 14 skipping mutation in non–small cell lung cancer patients in resource constrained community hospitals
Anurag Mehta, Shrinidhi Nathany, Aanchal Chopra, Sakshi Mattoo, Dushyant Kumar, Manoj Kumar Panigrahi
JPTM. 2021;55(5):324-329.   Published online 2021 September 2    DOI: https://doi.org/10.4132/jptm.2021.07.15

Excel Download

Robust home brew fragment sizing assay for detection of MET exon 14 skipping mutation in non–small cell lung cancer patients in resource constrained community hospitals
Journal of Pathology and Translational Medicine. 2021;55(5):324-329   Crossref logo
Link1 Link2 Link3

MET Immunohistochemistry Should Be Avoided in Selecting Non–small-cell Lung Cancers Requiring MET Exon 14 Skipping Mutation Analysis
Clinical Lung Cancer. 2019;20(3):e418-e420   Crossref logo
Link1 Link2

MET exon 14 skipping mutation positive non-small cell lung cancer: Response to systemic therapy
Lung Cancer. 2021;154:142-145   Crossref logo
Link1 Link2

P85.05 MET Exon 14 Skipping Mutation Positive Non-Small Cell Lung Cancer: A Population-Based Cohort
Journal of Thoracic Oncology. 2021;16(3):S670-S671   Crossref logo
Link1 Link2

Detection of MET exon 14 skipping mutations in non-small cell lung cancer: overview and community perspective
Expert Review of Anticancer Therapy. 2021;21(8):877-886   Crossref logo
Link1

Interstitial lung disease associated with capmatinib therapy in a patient with non‐small cell lung cancer harboring a skipping mutation of MET exon 14
Thoracic Cancer. 2020;12(4):549-552   Crossref logo
Link1 Link2 Link3

Novel MET exon 14 skipping analogs characterized in non-small cell lung cancer patients: A case study
Cancer Genetics. 2021;256-257:62-67   Crossref logo
Link1 Link2

MET exon 14 splicing mutation and its correlation with clinocopathological features in subjects with non-small cell lung cancer
Annals of Oncology. 2018;29:viii54   Crossref logo
Link1 Link2 Link3

Capmatinib for patients with non-small cell lung cancer with MET exon 14 skipping mutations: A review of preclinical and clinical studies
Cancer Treatment Reviews. 2021;95:102173   Crossref logo
Link1 Link2

The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping
Cancer Treatment Reviews. 2020;87:102022   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. J Pathol Transl Med has participated in CrossRef Text and Data Mining service since January 16, 2015.